The Trevena award includes $460,000 in direct funding, and access to millions of dollars worth of contracted research services.
The NIH has awarded this contract through its Blueprint Neurotherapeutics Network, which aims to develop new drugs for disorders of the central nervous system.
The Blueprint will fund both activities at Trevena, leverage resources at the 15 agency institutes and centers in the Network, and involve work by consultants and contractors.